MegaCurcumin Alovedic • Formulation-Based Approaches with Human Clinical Evidence
info@alovedic.com +91 98765 43210
Innovation Section

Innovation Is at the Heart of What We Do

We continuously explore new technologies, ingredients, delivery systems, and formulation approaches to create the next generation of nutraceutical solutions.

Clinical Pharmacokinetics

Formulation-Based (Strongest Effect)

Here are the advanced molecular delivery approaches with human clinical evidence behind them, engineered into our flagship MegaCurcumin technology:

Liquid Micellar Nano-Carrier Platform
MICELLE NANO-CARRIER
Human Peak Bioavailability +185x AUC
Carrier Platform Surfactant Micelles
Particle Size 10 - 30 nm Hydro
Peak Plasma (Tmax) 60 Minutes
Intestinal Route Enterocyte Endocytosis
Biomimetic Lipid Digestion Double-Blind Human PK Validated

Micellar / Liquid Micelle Forms

Curcumin encapsulated within surfactant micelle nano-spheres; widely recognized in clinical pharmacology for producing the highest recorded blood plasma concentrations.

Because native curcumin is non-polar and hydrophobic, it agglomerates in the aqueous digestive tract. Liquid micelle technology pre-emulsifies curcumin crystals into sub-30nm water-soluble spheres that bypass digestive emulsification, facilitating immediate absorption into mesenteric circulation.

Human Plasma Pharmacokinetics (0 - 24 Hours)
Standard 95%
Micellar (+185x)
Peak Cmax: 60 min (3,200 nmol/L) 0h 4h 8h 16h 24h
Clinical Metric: Total Plasma Area Under Curve (AUC) 185-Fold Superiority vs Standard Curcumin Extract
1
Gastric Shielding
Surfactant shell protects polyphenols from low stomach pH decomposition.
2
Mucosal Transit
Nano-droplets rapidly penetrate the unstirred intestinal water layer.
3
Systemic Uptake
Delivers bioactive unconjugated curcumin straight to mesenteric blood flow.
Finished Formats: Liquid Softgels RTD Wellness Drinks Oral Drops
Phytosome Phospholipid Bilayer Complex
PHYTOSOME BILAYER
Target Tissue Retention 4.2x Higher
Carrier Platform Phosphatidylcholine
Molecular Ratio 1:2 Botanical Complex
Elimination Half-Life Extended 24h Plateau
Cellular Target Cartilage & Endothelium
Cellular Membrane Biomimicry 30+ Human Clinical Trials

Phytosome / Lecithin Complexes

Curcumin complexed at a molecular level with non-GMO phospholipids, engineered specifically to enhance cellular membrane transit and deep musculoskeletal tissue retention.

Human cellular membranes are composed of a phospholipid bilayer. By complexing hydrophobic curcumin with natural phosphatidylcholine, the molecule is disguised as a membrane nutrient, facilitating direct cellular fusion and sustained tissue distribution in joints, micro-vessels, and organs.

Sustained Tissue Bio-Distribution (0 - 24 Hours)
Standard 95%
Phytosome (29x Sustained)
Sustained Plateau: 24h Joint Protection 0h 4h 8h 16h 24h
Clinical Metric: Cellular Translocation & Joint Cartilage Affinity 4.2x Greater Tissue Concentration than Native Curcumin
1
Phospholipid Pairing
Polar choline head and non-polar lipid tails anchor the curcumin molecule.
2
Bilayer Fusion
Naturally merges into cell membranes without requiring energy-dependent pumps.
3
Prolonged Residence
Provides extended systemic residence time, resisting rapid hepatic clearing.
Finished Formats: Joint & Cartilage Softgels Lipid Two-Piece Capsules Topical Emulsions
Sub-100nm Nanoparticle Dispersion
SUB-100NM NANO-MATRIX
Hydrodynamic Diameter < 85 nm
Particle Morphology Amorphous Nano-Core
Surface Area Gain > 12,000 m²/kg
Human Plasma AUC 27x Multiplier
Delivery Matrix Polymer Dispersed
Surface Area Amplification Solid Dose Dispersibility

Nanoparticles & Nano-Emulsions

Curcumin crystal particles engineered down to sub-100 nanometers and stabilized with hydrophilic polymeric matrices to achieve 100% water dispersibility.

By reducing particle diameter below 100 nanometers via wet bead milling and high-pressure homogenization, surface area increases by multiple orders of magnitude. The Noyes-Whitney dissolution equation demonstrates that this exponential surface expansion enables instantaneous dissolution in gastric fluids.

Rapid Dissolution Pharmacokinetics (0 - 24 Hours)
Standard 95%
Nanoparticles (27x)
Rapid Cmax: 90 min (27x AUC) 0h 4h 8h 16h 24h
Clinical Metric: Dissolution Velocity & Gastrointestinal Dispersibility Zero Pre-Digestion Required • Ideal for Functional Foods
1
Milling to <100nm
Destroys crystal lattice resistance to establish maximum dissolution speed.
2
Polymer Stabilization
Prevents re-agglomeration of particles across diverse beverage and food matrices.
3
Paracellular Diffusion
Sub-microscopic dimensions enable passive transit through cellular tight junctions.
Finished Formats: Functional Gummies Chewables & Lozenges Tablets & Capsules
Cyclodextrin Toroidal Hydro-Ring Complex
HYDRO-RING COMPLEX
Water Solubility Elevation > 10,000x
Oligosaccharide Ring Gamma-Cyclodextrin
Molecular Cavity Cone Hydrophobic Core
Human Plasma AUC 39x vs 95% Extract
Taste & Clarity 100% Transparent Solution
Molecular Ring Inclusion Clean-Label Oligosaccharide

Cyclodextrin Inclusion Complexes

Curcumin molecules encapsulated within natural bucket-shaped oligosaccharide rings — featuring a lipophilic internal cavity and an ultra-hydrophilic external surface.

Gamma-cyclodextrin rings create a molecular host-guest inclusion complex. The lipophilic inner core locks around the hydrophobic curcumin molecule, while the hydrophilic exterior dissolves instantly in cold water without turbidity, oil separation, or bitter botanical astringency.

Fast-Release Aqueous Pharmacokinetics (0 - 24 Hours)
Standard 95%
Cyclodextrin (39x)
Fast Tmax: 45 min (39x AUC) 0h 4h 8h 16h 24h
Clinical Metric: Molecular Inclusion & Clear Beverage Dissolution Completely Clear In Solution • Non-Sedimenting
1
Host-Guest Complex
Natural oligosaccharide ring traps hydrophobic curcumin without covalent bonds.
2
Rapid Hydro-Dispersal
Outer hydrophilic mantle allows instantaneous distribution in digestive juices.
3
Membrane Transfer
Releases monomeric free curcumin directly to the intestinal epithelial brush border.
Finished Formats: Instant Stickpacks Effervescent Powders Clear RTD Beverages
Clinical Pharmacokinetics Head-to-Head Benchmark
Scroll horizontally on mobile
Pharmacokinetic Parameter Standard Curcumin 95% Platform 01: Micellar Platform 02: Phytosome Platform 03: Nanoparticles Platform 04: Cyclodextrin
Human Bioavailability Multiplier (AUC) 1x (Baseline Reference) 185x (Highest Peak) 29x (Sustained Retention) 27x (High Surface Area) 39x (Aqueous Complex)
Peak Plasma Absorption Time (Tmax) 4.5 - 6.0 Hours (Delayed) 60 Minutes (Ultra-Fast) 2.5 - 3.5 Hours 90 Minutes 45 Minutes
Water Solubility in Digestive Fluid < 0.1 µg/mL (Insoluble) Completely Soluble Emulsion Lipid Bilayer Complex Sub-100nm Colloidal Dispersion Hydrophilic Cavity Solution
Cellular Membrane Translocation Agglomerates / Poor Diffusion Enterocyte Endocytosis Direct Phospholipid Fusion Tight Junction Paracellular Aqueous Surface Release
Primary Clinical Target Area Localized Bowel Lumen Only Systemic Blood Circulation Joint Cartilage & Endothelium Immune & Inflammatory Health Cognitive & Metabolic Delivery
Ideal Finished Dosage Formats Standard Bulk Tablets Liquid Softgels & RTD Shots Joint & Mobility Softgels Functional Gummies & Chewables Dissolving Stickpacks & Sachets
Liposomal micellar delivery vehicle crossing cellular membrane
Mechanism of Action

Why Delivery Systems Determine Clinical Efficacy

Native curcumin faces severe bioavailability barriers: poor aqueous solubility (< 11 ng/mL), chemical instability at intestinal pH (>6.8), rapid Phase II hepatic glucuronidation, and low mucosal uptake. Without advanced pharmaceutical carrier engineering, less than 1% reaches systemic circulation.

MegaCurcumin encapsulates curcumin molecules in bio-compatible supramolecular assemblies that protect the active compound through gastric transit and facilitate immediate transport across enterocytes into systemic circulation.

View Products
Our Process

Research → Discovery → Formulation → Validation → Commercialization

From concept development to commercialization, we work with partners to transform innovative ideas into market-ready solutions.

Research

Identify emerging health needs and promising ingredients.

Development

Create differentiated formulations using advanced technologies.

Validation

Evaluate quality, performance, safety, and scientific evidence.

Commercialization

Transform innovative concepts into scalable market solutions.